Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment

Detalles Bibliográficos
Autores principales: Yurttutan, Sadık, Gullu, Utku Ufuk, Ipek, Sevcan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Ce - Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889409/
https://www.ncbi.nlm.nih.gov/pubmed/33598871
http://dx.doi.org/10.1007/s11739-021-02663-6
_version_ 1783652303231778816
author Yurttutan, Sadık
Gullu, Utku Ufuk
Ipek, Sevcan
author_facet Yurttutan, Sadık
Gullu, Utku Ufuk
Ipek, Sevcan
author_sort Yurttutan, Sadık
collection PubMed
description
format Online
Article
Text
id pubmed-7889409
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-78894092021-02-18 Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment Yurttutan, Sadık Gullu, Utku Ufuk Ipek, Sevcan Intern Emerg Med Ce - Letter to the Editor Springer International Publishing 2021-02-18 2021 /pmc/articles/PMC7889409/ /pubmed/33598871 http://dx.doi.org/10.1007/s11739-021-02663-6 Text en © Società Italiana di Medicina Interna (SIMI) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Ce - Letter to the Editor
Yurttutan, Sadık
Gullu, Utku Ufuk
Ipek, Sevcan
Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment
title Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment
title_full Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment
title_fullStr Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment
title_full_unstemmed Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment
title_short Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment
title_sort anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe covid‑19 pneumonia and moderate hyperinflammation. a retrospective cohort study: comment
topic Ce - Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889409/
https://www.ncbi.nlm.nih.gov/pubmed/33598871
http://dx.doi.org/10.1007/s11739-021-02663-6
work_keys_str_mv AT yurttutansadık anakinraaftertreatmentwithcorticosteroidsaloneorwithtocilizumabinpatientswithseverecovid19pneumoniaandmoderatehyperinflammationaretrospectivecohortstudycomment
AT gulluutkuufuk anakinraaftertreatmentwithcorticosteroidsaloneorwithtocilizumabinpatientswithseverecovid19pneumoniaandmoderatehyperinflammationaretrospectivecohortstudycomment
AT ipeksevcan anakinraaftertreatmentwithcorticosteroidsaloneorwithtocilizumabinpatientswithseverecovid19pneumoniaandmoderatehyperinflammationaretrospectivecohortstudycomment

Ejemplares similares